|
Publications: |
A Guide to the Clinical Care of Women with HIV/AIDS, 2005 edition |
<
Previous
| Home | Next >
Indexes
Index of Topics Nos A B
C D E
FGH
I J K
L
M N
O P Q
R S T
U V W XY Z
Nos TOP
A
TOP
abnormal uterine bleeding |
access to care |
acute illness |
adherence |
|
|
counseling during pregnancy |
|
and depression |
|
improvement, table |
|
measures of |
|
predictors |
|
special populations |
adolescents |
|
and adherence |
|
care requirements |
|
epidemiology |
|
interview menmonic (table) |
|
pregnancy counseling |
Adult Aids Clinical Trial Group |
advance care planning |
|
counseling during pregnancy |
|
at end of life |
adverse effects |
African American patients |
AIDS |
|
incidence in US |
|
progression likelihood |
AIDS Alliance for Children, Youth & Families |
AIDS-defining illness (table) |
AIDS dementia complex |
|
incidence |
|
management |
AIDS Education and Training Centers |
AIDS Education Global Information System |
AIDS Info NYC |
AIDS Risk Reduction model |
AIDS Treatment Data Network |
AIDSInfo |
AIDSMeds.com |
alcohol |
alcohol addiction |
alcohol intoxication |
allergies, topical |
altered status |
amenorrhea |
American Academy of HIV Medicine |
American College of Obstetricians and Gynecologists |
American Foundation for AIDS Research |
American Psychological Association Office on AIDS |
amniocentesis |
anal squamous intraepithelial lesions |
anemia |
|
management |
|
during pregnancy, nutritional aspects |
anovulation |
antioxidants |
Antiretroviral Pregnancy Registry, and pregnancy |
anxiety |
|
medications (table) |
|
misperceptions (table) |
aphthous ulcers |
|
genital (image) |
|
genital, management |
|
oral (image) |
ARV therapy. see also individual drugs and classes in drugs index |
|
adverse events |
|
adverse fetal effects |
|
adverse maternal effects |
|
adverse pregnancy effects |
|
agents |
|
indications (table) |
|
initial regimens (table) |
|
interactions with psychotropics (table) |
|
intrapartum |
|
in neonates |
|
nutritional considerations, and patients |
|
nutritional counseling |
|
perinatal HIV transmission |
|
for postexposure prophylaxis (table) |
|
pregnancy, pharmacokinetics during, table |
|
pregnancy, use during, table |
|
principles |
|
principles, during pregnancy, table |
|
regimen change after treatment failure (table) |
|
in substance abusers |
|
treatment guidelines |
Asia |
Association of Nurses in AIDS Care |
assumptions (table) |
atypical glandular cells |
avascular necrosis |
B
TOP
C TOP
Canadian AIDS Treatment Information Exchange |
candidiasis |
|
images |
|
management, and vaginal discharge, table |
|
during pregnancy |
CD4 count |
|
associated complications (table) |
|
baseline evaluation |
|
perinatal transmission |
|
in pregnancy |
|
testing, during pregnancy |
CD4 subset analysis (table) |
CDC Division of HIV/AIDS Prevention |
CDC National Prevention Information Network |
cervical cancer |
|
in Brazil |
|
in HIV patients |
|
prevalence in Zambia |
cervical caps |
cervical dysplasia |
cervical ectopy (table), and HIV s usceptibility |
cervical intrepithelial neoplasia (image) |
cervical lesions |
cervicitis (image) |
cervix development |
cesarean delivery, and Intrapartum |
chancres (image) |
chancroid |
|
image |
|
management |
chemistry panel |
childbearing imperative |
children, and adherence |
chlamydia |
|
image |
|
management |
chorioamnionitis |
chorionic villus sampling |
chronic care model |
circumcision |
clinical failure |
clinical services pyramid |
cocaine addiction |
cocaine use |
coccidiomycosis |
colorectal cancer |
colposcopy |
|
genital warts |
|
recommendations (table) |
comfort, at end of life |
communication |
|
across culture, table |
|
breaking bad news |
|
at end of life |
|
essentials of |
|
and risk assessment |
|
risk reduction counseling |
communicating about (table) |
Community Program for Clinical Research on AIDS |
complementary therapies |
|
communicating about (table) |
|
at end of life |
concomitant illness |
condoms |
|
counseling during pregnancy |
|
practices in Brazil |
|
practices in Zambia |
|
as prevention tool |
|
use influences (table), table |
condoms (female), table |
condoms (male) |
|
characteristics (table) |
|
HIV transmission |
condyloma latum (image) |
condylomata acuminata (image) |
confidentiality |
|
and adolescents |
|
essentials of |
consultations |
context, in communication |
contraception |
|
access in Brazil |
|
communicating about |
|
counseling during pregnancy |
|
effect on transmission (table) |
|
HIV transmission |
|
and HIV transmission |
|
methods (table) |
|
motivations |
|
prevention effectiveness (table) |
contraction stress testing |
core values |
|
African American culture |
|
Hispanic culture |
cough |
counseling |
|
about testing, table |
|
of adolescents |
|
after occupational exposure |
|
essentials of |
|
influence on prevention |
|
initial visit |
|
in practice |
|
during pregnancy |
|
pregnant patients |
counselors |
Critical Path AIDS Project |
Crohn’s disease |
cryptococcosis |
Cryptococcus neoformans |
|
management |
|
prophylaxis (table) |
cultural competence |
|
at end of life |
|
risk reduction counseling |
|
treating HIV patients |
cyryptosporidiosis |
cytomegalovirus |
|
baseline evaluation |
|
management, and gynecological problems |
|
during pregnancy, and opportunistic infections |
|
prophylaxis (table) |
D TOP
E TOP
F TOP
G TOP
H TOP
I TOP
J TOP
K TOP
L TOP
M TOP
N TOP
O TOP
P TOP
pain |
|
|
scope of |
pain relief |
|
barriers, table |
|
principles |
|
WHO ladder (table) |
Pap smears |
|
abnormal, management of (table) |
|
anal, technique |
|
baseline evaluation |
|
recommendations |
|
use, table |
papillomavirus |
|
image |
|
during pregnancy |
Partnership for Caring |
patient education |
patient evaluation |
|
follow-up visits |
|
initial visit |
|
intake flow sheet |
Pediatric AIDS Clinical Trials Group |
Pediatric Classification System (table) |
pelvic examination |
pelvic inflammatory disease |
|
image |
|
IUD use |
|
management |
pelvic mass |
pelvic pain |
percutaneous umbilical blood sampling |
perimenopause |
perinatal transmission |
|
in Brazil |
|
factors |
|
prevention regimen comparison (table) |
|
prevention strategies |
|
trials review, table |
peripheral neuropathy |
pH (vaginal) (table), |
pharmacokinetics |
|
ARV/psychotropics interactions (table) |
|
during pregnancy, table |
|
in pregnancy |
physical examination |
placental abruption |
pneumococcal vaccine |
Pneumocystis carinii pneumonia |
|
as diagnostic marker |
|
management |
|
neonatal prophylaxis |
|
during pregnancy, table |
|
prophylaxis (table) |
polio vaccine |
polymerase chain reaction (PCR) |
Population Council |
postexposure prophylaxis |
|
mucous membrane exposure (table) |
|
percutaneous exposure (table) |
|
after sexual contact |
|
site management |
postpartum care |
poverty |
|
access to care |
|
among adolescents |
|
in Brazil |
|
and seeking care |
|
treatment barrier in Zambia |
pregnancy |
|
adverse outcomes (table) |
|
adverse outcomes, ARV therapy |
|
among adolescents |
|
antepartum history |
|
ARV pharmacokinetics, table |
|
ARV therapy during, table |
|
drug categories (table) |
|
drug pharmacokinetics |
|
HIV natural history |
|
laboratory evaluation (table) |
|
nutritional status during |
|
and postexposure prophylaxis |
|
substance abuse |
|
testing |
|
vs. amenorrhea |
prenatal care |
|
in Brazil |
|
nutritional counseling |
preterm delivery |
prevention messages |
prevention models |
priorities (table) |
prisons, substance abusers in |
prognosis |
|
in depressed patients |
|
determining |
progressive multifocal leukoencephalopathy |
Project Inform |
provider-patient relationship |
|
and adherence, table |
|
cautions for providers |
|
communication across culture, table |
providers |
pruritus |
psychosis |
|
medications (table) |
|
misperceptions (table) |
psychosocial issues |
|
among adolescents |
|
at diagnosis |
|
intervention suggestions |
puberty |
pyosalpinx |
Q TOP
R TOP
S TOP
T TOP
U TOP
V TOP
W TOP
X TOP
Y TOP
Z TOP
|